Brachytherapy
Volume 6, Issue 2 , Page 78, April 2007

Clinical outcomes of a Phase II, multi-institutional Cesium-131 permanent prostate brachytherapy trial

  • Bradley R. Prestidge, M.D.

      Affiliations

    • Texas Cancer Clinic, San Antonio, TX
    • Radiological Sciences, UTHSCSA, San Antonio, TX
  • ,
  • William S. Bice, Ph.D.

      Affiliations

    • Radiological Sciences, UTHSCSA, San Antonio, TX
    • Southwest Cancer Foundation, San Antonio, TX

OR-1 Presentation Time: 9:00 AM

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This work was supported by Isoray Medical, manufacturers of the source type used in the study.

PII: S1538-4721(07)00038-4

doi:10.1016/j.brachy.2007.02.006

Brachytherapy
Volume 6, Issue 2 , Page 78, April 2007